Grace Therapeutics
GRCE
#10295
Rank
A$55.64 M
Marketcap
A$3.42
Share price
5.80%
Change (1 day)
-25.53%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2025 (TTM): -A$14.8 Million

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$23.72 Million, an increase over its 2023 earnings that were of -A$70.11 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$14.8 Million-37.63%
2024 -A$23.72 Million-66.16%
2023 -A$70.11 Million161.72%
2022 -A$26.79 Million60.58%
2021 -A$16.69 Million-462.11%
2020 A$4.6 M
2018 -A$36.29 Million
2015 -A$5.89 Million
2013 -A$14.31 Million49.55%
2012 -A$9.57 Million